Skip to main content
Screener/Healthcare/Biotechnology

MLYS — Mineralys Therapeutics, Inc.

NASDAQ
$27.20-2.25 (-7.65%)
Mid CapUnder $50HealthcareLow Beta
$22.30
$47.65
$26.94
$29.83
EPS (TTM)$-2.05
P/E Ratio-13.48
Dividend Yield—
Market Cap$2.55B
Volume571K
Prev Close$29.40
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$39.3M$-0.47——
Q4 '25$0-$32.2M$-0.40——
Q3 '25$0-$36.9M$-0.52——
Q2 '25$0-$43.3M$-0.66——
Q1 '25$0-$42.2M$-0.79——
Q4 '24$0-$48.9M$-0.98——
Q3 '24$0-$56.3M$-1.13——
Q2 '24$0-$41.0M$-0.83——
Get Your Daily Market Recap